Market Cap 342.17M
Revenue (ttm) 22.47M
Net Income (ttm) -78.62M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -349.89%
Debt to Equity Ratio 0.37
Volume 6,378,656
Avg Vol 7,343,204
Day's Range N/A - N/A
Shares Out 814.68M
Stochastic %K 20%
Beta 0.83
Analysts Sell
Price Target $1.43

Company Profile

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time d...

Industry: Medical Devices
Sector: Healthcare
Phone: 301 515 7260
Fax: 833 552 7007
Address:
20451 Seneca Meadows Parkway, Germantown, United States
Merlintrader
Merlintrader Aug. 3 at 4:11 PM
Senseonics Holdings ($SENS) Stock Hub: Eversense 365, Q2 Earnings, Gemini Pipeline and Dilution Risk https://www.merlintrader.com/senseonics-holdings-stock-hub/
0 · Reply
aljudaia92
aljudaia92 Aug. 3 at 1:50 PM
$SENS 6.5 $ before the end of this week, then based on earning 7.9 then 10 $
3 · Reply
Barnstormer
Barnstormer Aug. 1 at 2:04 PM
$SENS A strong CEO would be embarrassed and motivated every time he see's his main competition's (DEXCOM) stock price jump 12% in a single day. He should lay awake at night thinking why his performance is so inferior and of ways to improve. He should be making early morning calls to his management team motivating them to improve their performance. DEXCOM has in inferior product, yet they are considered to be the best based on sales. Apparently our CEO sleeps too well at night, doesn't stimulate exceptional performance from his team and is satisfied with running a distant 3rd. Sad, so sad.
2 · Reply
AndreaGuerrero1105
AndreaGuerrero1105 Aug. 1 at 5:48 AM
$SENS Senseonics is developing long-duration continuous glucose monitoring technology. Broader physician adoption and commercial execution remain key milestones for future expansion.
1 · Reply
Groundsize
Groundsize Jul. 31 at 10:07 PM
$SENS good job management! Back to pre reverse split price! You can always tell when a company is just that perfectly ran when that happens!
0 · Reply
Lupus_Leoque_Holdings
Lupus_Leoque_Holdings Jul. 31 at 9:22 PM
$SENS This combined with an 80% revenue increase YOY cannot scream “BUY” any louder. Buying 200 more shares and averaging down.
0 · Reply
Punpire
Punpire Jul. 31 at 5:14 PM
$SENS The real question is when is the next R/S. For a company that has been in business 3 years longer than Dexcom, 6-9k users is Pathetic. Avoid this stock until Timothy Goodnow is replaced. This stock is the Betamax of CGM's.
1 · Reply
aljudaia92
aljudaia92 Jul. 31 at 5:10 PM
$SENS Nevr sell now, remember these facts from last meeting,: - strong revenue growth of nearly 87%, an increase in full-year guidance, clear margin improvement, - strong momentum in the DTC channel, - expansion of Eon Care to make insertions easier, - reorders coming in above plan, - early European expansion, and a promising integration with twiist AID. So the real question is not what the stock does in a day or a week, but whether the company continues turning its strong technology into real commercial growth.
2 · Reply
aljudaia92
aljudaia92 Jul. 31 at 1:46 PM
$SENS BlackRock doubles down on SENS! A spectacular jump in ownership from 568k shares to 2.764 million shares, securing a 6.6% stake in the company! When the biggest whale in the market loads up this heavily, it's a clear signal that the stock is gearing up for a brand new chapter. Buckle up!
4 · Reply
Barnstormer
Barnstormer Jul. 31 at 11:18 AM
$SENS Dexcom a totally inferior product up $6.50 pm today. A one day jump bigger than our entire share price. Tim your slow playing the insertion expansion and promotion of Eversense along with you ill advised RS + move to NASDAQ has cost your loyal shareholders the just rewards we deserve for supporting you all of these years. Retirement would be a good path. Think about it.
1 · Reply
Latest News on SENS
Senseonics price target lowered to $18 from $20 at Mizuho

2026-07-15T11:31:55.000Z - 19 days ago

Senseonics price target lowered to $18 from $20 at Mizuho


Senseonics announces further data from study of Eversense 365

2026-06-07T22:35:54.000Z - 2 months ago

Senseonics announces further data from study of Eversense 365


Senseonics Holdings Transcript: Investor update

Jun 6, 2026, 8:00 AM EDT - 2 months ago

Senseonics Holdings Transcript: Investor update


Senseonics Holdings Transcript: AGM 2026

May 20, 2026, 10:00 AM EDT - 2 months ago

Senseonics Holdings Transcript: AGM 2026


Senseonics price target lowered to $8 from $9 at Stifel

2026-05-11T11:48:30.000Z - 3 months ago

Senseonics price target lowered to $8 from $9 at Stifel


Senseonics price target lowered to $12 from $20 at Lake Street

2026-05-08T16:19:10.000Z - 3 months ago

Senseonics price target lowered to $12 from $20 at Lake Street


Senseonics reports Q1 EPS (71c), consensus (70c)

2026-05-07T21:38:40.000Z - 3 months ago

Senseonics reports Q1 EPS (71c), consensus (70c)


Senseonics Holdings Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Senseonics Holdings Earnings Call Transcript: Q1 2026


Senseonics Holdings Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Senseonics Holdings Earnings release: Q1 2026


Senseonics Holdings Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Senseonics Holdings Quarterly report: Q1 2026


Senseonics announces common stock offering, no amount given

2026-04-30T20:07:00.000Z - 3 months ago

Senseonics announces common stock offering, no amount given


Senseonics Holdings Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 4 months ago

Senseonics Holdings Proxy statement: Proxy filing


Senseonics Holdings Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 4 months ago

Senseonics Holdings Proxy statement: Proxy filing


Senseonics Holdings Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 4 months ago

Senseonics Holdings Proxy statement: Proxy filing


Senseonics Holdings Proxy statement: Proxy filing

Mar 27, 2026, 8:00 AM EDT - 4 months ago

Senseonics Holdings Proxy statement: Proxy filing


Senseonics Holdings Earnings Call Transcript: Q4 2025

Mar 2, 2026, 4:30 PM EST - 5 months ago

Senseonics Holdings Earnings Call Transcript: Q4 2025


Senseonics Holdings Annual report: Q4 2025

Mar 2, 2026, 4:30 PM EST - 5 months ago

Senseonics Holdings Annual report: Q4 2025


Senseonics Holdings Earnings release: Q4 2025

Mar 2, 2026, 4:30 PM EST - 5 months ago

Senseonics Holdings Earnings release: Q4 2025


Senseonics reports Q4 EPS (46c), consensus (43c)

2026-03-02T21:15:11.000Z - 5 months ago

Senseonics reports Q4 EPS (46c), consensus (43c)


Senseonics sees FY26 revenue $58M-$62M, consensus $60.38M

2026-03-02T21:14:02.000Z - 5 months ago

Senseonics sees FY26 revenue $58M-$62M, consensus $60.38M


Senseonics sees FY25 revenue $58M-$62M, consensus $59.73M

2026-01-12T13:16:59.000Z - 7 months ago

Senseonics sees FY25 revenue $58M-$62M, consensus $59.73M


Senseonics announces transfer to Nasdaq stock exchange

2025-11-10T13:25:56.000Z - 9 months ago

Senseonics announces transfer to Nasdaq stock exchange


Senseonics Holdings Slides: Corporate Presentation

Nov 9, 2025, 6:00 PM EST - 9 months ago

Senseonics Holdings Slides: Corporate Presentation


Senseonics Holdings Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:30 PM EST - 9 months ago

Senseonics Holdings Earnings Call Transcript: Q3 2025


Senseonics Holdings Quarterly report: Q3 2025

Nov 5, 2025, 4:30 PM EST - 9 months ago

Senseonics Holdings Quarterly report: Q3 2025


Senseonics Holdings Earnings release: Q3 2025

Nov 5, 2025, 4:30 PM EST - 9 months ago

Senseonics Holdings Earnings release: Q3 2025


Senseonics Holdings Transcript: Status Update

Sep 4, 2025, 8:00 AM EDT - 11 months ago

Senseonics Holdings Transcript: Status Update


Senseonics Holdings Press release: Status Update

Sep 4, 2025, 8:00 AM EDT - 11 months ago

Senseonics Holdings Press release: Status Update


Senseonics Holdings Proxy statement: Proxy Filing

Aug 18, 2025, 8:00 AM EDT - 1 year ago

Senseonics Holdings Proxy statement: Proxy Filing


Senseonics Holdings Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Senseonics Holdings Earnings Call Transcript: Q2 2025


Senseonics Holdings Quarterly report: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Senseonics Holdings Quarterly report: Q2 2025


Senseonics Holdings Earnings release: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Senseonics Holdings Earnings release: Q2 2025


Senseonics Holdings Proxy statement: Proxy Filing

Aug 6, 2025, 8:00 AM EDT - 1 year ago

Senseonics Holdings Proxy statement: Proxy Filing


Senseonics Holdings Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Senseonics Holdings Earnings Call Transcript: Q1 2025


Senseonics Holdings Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Senseonics Holdings Quarterly report: Q1 2025


Senseonics Holdings Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Senseonics Holdings Earnings release: Q1 2025


Senseonics Holdings Proxy statement: Proxy Filing

Apr 10, 2025, 8:00 AM EDT - 1 year ago

Senseonics Holdings Proxy statement: Proxy Filing


Senseonics Holdings Proxy statement: Proxy Filing

Apr 10, 2025, 8:00 AM EDT - 1 year ago

Senseonics Holdings Proxy statement: Proxy Filing


Senseonics Holdings Earnings Call Transcript: Q4 2024

Mar 3, 2025, 4:30 PM EST - 1 year ago

Senseonics Holdings Earnings Call Transcript: Q4 2024


Senseonics Holdings Annual report: Q4 2024

Mar 3, 2025, 4:30 PM EST - 1 year ago

Senseonics Holdings Annual report: Q4 2024


Senseonics Holdings Earnings release: Q4 2024

Mar 3, 2025, 4:30 PM EST - 1 year ago

Senseonics Holdings Earnings release: Q4 2024


Senseonics Holdings Proxy statement: Proxy Filing

Dec 9, 2024, 7:00 AM EST - 1 year ago

Senseonics Holdings Proxy statement: Proxy Filing


Senseonics Holdings Proxy statement: Proxy Filing

Nov 29, 2024, 7:00 AM EST - 1 year ago

Senseonics Holdings Proxy statement: Proxy Filing


Senseonics Holdings Proxy statement: Proxy Filing

Nov 19, 2024, 7:00 AM EST - 1 year ago

Senseonics Holdings Proxy statement: Proxy Filing


Senseonics Holdings Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Senseonics Holdings Earnings Call Transcript: Q3 2024


Senseonics Holdings Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Senseonics Holdings Quarterly report: Q3 2024


Senseonics Holdings Earnings release: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Senseonics Holdings Earnings release: Q3 2024


Eversense 365 Launches in the US: One Year. One CGM.

Oct 1, 2024, 11:00 AM EDT - 1 year ago

Eversense 365 Launches in the US: One Year. One CGM.


Senseonics Holdings Earnings Call Transcript: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Senseonics Holdings Earnings Call Transcript: Q2 2024


Senseonics Holdings Quarterly report: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Senseonics Holdings Quarterly report: Q2 2024


Senseonics Holdings Earnings release: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Senseonics Holdings Earnings release: Q2 2024


Senseonics Holdings Slides: FY 2024

May 15, 2024, 3:35 PM EDT - 2 years ago

Senseonics Holdings Slides: FY 2024


Senseonics Holdings Earnings Call Transcript: Q1 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

Senseonics Holdings Earnings Call Transcript: Q1 2024


Senseonics Holdings Quarterly report: Q1 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

Senseonics Holdings Quarterly report: Q1 2024


Senseonics Holdings Earnings release: Q1 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

Senseonics Holdings Earnings release: Q1 2024


Eversense® CGM System Receives iCGM Designation by the US FDA

Apr 30, 2024, 7:00 AM EDT - 2 years ago

Eversense® CGM System Receives iCGM Designation by the US FDA


Senseonics Holdings Proxy statement: Proxy Filing

Apr 12, 2024, 8:00 AM EDT - 2 years ago

Senseonics Holdings Proxy statement: Proxy Filing


Senseonics Holdings Proxy statement: Proxy Filing

Apr 12, 2024, 8:00 AM EDT - 2 years ago

Senseonics Holdings Proxy statement: Proxy Filing


Senseonics Holdings Proxy statement: Proxy Filing

Apr 2, 2024, 8:00 AM EDT - 2 years ago

Senseonics Holdings Proxy statement: Proxy Filing


Merlintrader
Merlintrader Aug. 3 at 4:11 PM
Senseonics Holdings ($SENS) Stock Hub: Eversense 365, Q2 Earnings, Gemini Pipeline and Dilution Risk https://www.merlintrader.com/senseonics-holdings-stock-hub/
0 · Reply
aljudaia92
aljudaia92 Aug. 3 at 1:50 PM
$SENS 6.5 $ before the end of this week, then based on earning 7.9 then 10 $
3 · Reply
Barnstormer
Barnstormer Aug. 1 at 2:04 PM
$SENS A strong CEO would be embarrassed and motivated every time he see's his main competition's (DEXCOM) stock price jump 12% in a single day. He should lay awake at night thinking why his performance is so inferior and of ways to improve. He should be making early morning calls to his management team motivating them to improve their performance. DEXCOM has in inferior product, yet they are considered to be the best based on sales. Apparently our CEO sleeps too well at night, doesn't stimulate exceptional performance from his team and is satisfied with running a distant 3rd. Sad, so sad.
2 · Reply
AndreaGuerrero1105
AndreaGuerrero1105 Aug. 1 at 5:48 AM
$SENS Senseonics is developing long-duration continuous glucose monitoring technology. Broader physician adoption and commercial execution remain key milestones for future expansion.
1 · Reply
Groundsize
Groundsize Jul. 31 at 10:07 PM
$SENS good job management! Back to pre reverse split price! You can always tell when a company is just that perfectly ran when that happens!
0 · Reply
Lupus_Leoque_Holdings
Lupus_Leoque_Holdings Jul. 31 at 9:22 PM
$SENS This combined with an 80% revenue increase YOY cannot scream “BUY” any louder. Buying 200 more shares and averaging down.
0 · Reply
Punpire
Punpire Jul. 31 at 5:14 PM
$SENS The real question is when is the next R/S. For a company that has been in business 3 years longer than Dexcom, 6-9k users is Pathetic. Avoid this stock until Timothy Goodnow is replaced. This stock is the Betamax of CGM's.
1 · Reply
aljudaia92
aljudaia92 Jul. 31 at 5:10 PM
$SENS Nevr sell now, remember these facts from last meeting,: - strong revenue growth of nearly 87%, an increase in full-year guidance, clear margin improvement, - strong momentum in the DTC channel, - expansion of Eon Care to make insertions easier, - reorders coming in above plan, - early European expansion, and a promising integration with twiist AID. So the real question is not what the stock does in a day or a week, but whether the company continues turning its strong technology into real commercial growth.
2 · Reply
aljudaia92
aljudaia92 Jul. 31 at 1:46 PM
$SENS BlackRock doubles down on SENS! A spectacular jump in ownership from 568k shares to 2.764 million shares, securing a 6.6% stake in the company! When the biggest whale in the market loads up this heavily, it's a clear signal that the stock is gearing up for a brand new chapter. Buckle up!
4 · Reply
Barnstormer
Barnstormer Jul. 31 at 11:18 AM
$SENS Dexcom a totally inferior product up $6.50 pm today. A one day jump bigger than our entire share price. Tim your slow playing the insertion expansion and promotion of Eversense along with you ill advised RS + move to NASDAQ has cost your loyal shareholders the just rewards we deserve for supporting you all of these years. Retirement would be a good path. Think about it.
1 · Reply
alderson95
alderson95 Jul. 31 at 8:36 AM
$SENS we will see
0 · Reply
SuperGreenToday
SuperGreenToday Jul. 31 at 2:53 AM
$SENS Share Price: $5.07 Contract Selected: Jan 15, 2027 $5 Calls Buy Zone: $0.85 – $1.05 Target Zone: $1.60 – $1.95 Potential Upside: 77% ROI Time to Expiration: 168 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
PattyPooner
PattyPooner Jul. 30 at 10:49 PM
$SENS greedy me wants it to stay under 5 a while longer to add more, but whats interesting is shares available has largely stayed the same while short interest has increased. There’s barely any retail interest to buy or sell, just a handful of people adding and a lot of stubborn bagholders with very high avgs, a short term squeeze would send to 14 before backtesting supports, but i’d say thats only like 5% chance if that. Only thing i know is shorts gonna have a bad time trying to close when no one is selling. Only certainty i know, the company is making moves towards profitability and I’m here until that happens at a minimum, a squeeze would just be fun to watch in the meantime.
0 · Reply
pathfinder63
pathfinder63 Jul. 30 at 10:36 PM
$SENS Even Blockrock could lift us. Ended up with 5$. The only was is exceptional revenue grow and profitability for sens. The rest is just air.
0 · Reply
Barnstormer
Barnstormer Jul. 30 at 9:16 PM
$SENS I have decided if I ever want to see my investment climb out of the red I have to be proactive in raising awareness. MY GP has a large practice in the San Diego area with 3 NPs serving a diabetic patient base of around 3500. I asked my GP and his staff if they were prescibing Eversense. They had never heard of it, but after my brief tutorial they said they would be interested in learning more. I contacted Senseonics customer care and explained what I just shared here. I got an email the next day from the SENS rep wanting to meet. Next week I will be introducing her to my GP's group. Wish me luck
1 · Reply
BMWLTWM3
BMWLTWM3 Jul. 30 at 6:56 PM
$SENS Blackrock has significantly increased their holdings; now 6.6% of SENS. May 13F was 568k, now they own 2.764m
1 · Reply
BMWLTWM3
BMWLTWM3 Jul. 30 at 6:34 PM
$SENS Blackrock's last 13F filing looks like May 13, 2026
1 · Reply
pathfinder63
pathfinder63 Jul. 30 at 5:39 PM
$SENS Blockrock disclosed %6.6 stake in sens and this is still trying to stay above 5$. This news one more time proves that, only way for Sens to go up is exceptional revenue growth and profitability. Whatever the rest Tim does won't change the reality. Revenue guidance should have been 90M+ for 2026. Tim is knows for putting low revenue guidance and explaining the succes with nonsense percentage increase while cash burn rate out of roof. Waiting for dump back to under 5
1 · Reply
alderson95
alderson95 Jul. 30 at 4:15 PM
1 · Reply
Waterman148
Waterman148 Jul. 30 at 3:38 PM
$SENS ok what did they they just release from corporate black rock sell or buy
0 · Reply
aljudaia92
aljudaia92 Jul. 29 at 8:25 PM
$SENS This only tracks Android downloads. Multiply that number by 3 to factor in iOS users, which means we’re looking at roughly 2,000 downloads per month. For a prescription medical app, that is fantastic growth!
3 · Reply
aljudaia92
aljudaia92 Jul. 29 at 6:57 PM
$SENS I’m speaking from facts because I personally attended the latest earnings call. I’ve thoroughly analyzed their financial results, growth metrics, guidance, and several key indicators. Everything points to SENS being a winning bet—there is zero emotion involved here. Just go back and read the latest earnings transcript. The company’s challenge has shifted from whether the market will accept the product, to a pure execution and marketing challenge.
1 · Reply